|
CEimpact |
Share:
|
OverviewAs an industry leader in pharmacy education and training, CEI leverages expertise, technology and partnerships. We provide impactful lifelong learning which enhances patient care, strengthens student and resident teaching, supports businesses and advances pharmacy careers. We’ll help you make learning a habit through individual courses and course subscriptions for pharmacists, preceptors, pharmacy technicians, and student pharmacists. |
COVID-19 Vaccine Myth Busters (Pharmacist)
Recommendations regarding COVID-19 immunizations are being updated frequently. This session will discuss the safety and efficacy data available for the COVID-19 vaccines that have received an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). Included in the discussion will be the mechanism of action and a comparison of dosage, schedule, and storage for the available ...
|
|
COVID-19 Vaccine Myth Busters (Technician)
Recommendations regarding COVID-19 immunizations are being updated frequently. This session will discuss the safety and efficacy data available for the COVID-19 vaccines that have received an Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA). Included in the discussion will be the mechanism of action and a comparison of dosage, schedule, and storage for the available ...
|
|
qFriday: Clinical Question Annual Subscription
WHAT IS IT?
qFriday is a 15 minute CPE course sent directly to your email inbox every Friday. Cases are about current clinical topics that have immediate application to your practice.
HOW DOES IT WORK?
1. Check your email every Friday
2. Complete the 15 minute course
3. Get your CPE
WHY qFRIDAY?
The goal is to be continually learning, striving to stay at the top of our game. qFriday ...
|
|
The Safety of Opioid Use in Chronic Obstructive Pulmonary Disease
This session will evaluate the safety of opioid therapy among patients with chronic obstructive pulmonary disease (COPD). The session will cover existing safety and effectiveness evidence from clinical trials, and present the latest data from observational studies. The presentation will include a discussion of the strengths and disadvantages of observational study designs along with implications...
|
|